AgeRate Biological Age Testing Kit + Reports

The exact route exposes a one-time price and the provider publishes a 30-day refund policy plus sample-failure remedies. The offer is expensive relative to the publicly documented evidence because exact lab, assay, report, and turnaround details remain unresolved, and the refund boundary becomes restrictive once a sample reaches the laboratory.

AgeRate names ten report areas and claims more than 50,000 epigenetic markers, which gives the buyer a meaningful high-level scope. The exact marker-to-report mapping, inclusion rules, and any omitted components are not publicly documented, so coverage cannot be audited at the level required for a stronger result.

The documented biological-age and longevity-trait question is directly aligned with the provider's stated epigenetic measurements and reports. Relevance is limited because AgeRate also markets future-illness and health-risk language while its Terms restrict the service to informational, educational, and research use and reject diagnostic or clinical interpretation.

The provider says its app reports include scientific background, measurement details, personalized recommendations, and references, and its Terms disclose that results are limited and non-deterministic. No public sample report, ranges, uncertainty display, or concrete follow-up pathway was available, so the buyer cannot independently assess how the report will be interpreted.

AgeRate identifies capillary blood, the TASSO+ collection device, DNA methylation analysis, and an accredited or CLIA-CAP laboratory. Reliability remains materially bounded by the lack of a named laboratory, assay platform, public performance statistics, and the provider's disclosure that transport can add variability and reported scores or traits are not clinically validated or tested.

The at-home TASSO+ collection, mail-back workflow, included return shipping, processing guidance, replacement path, and app delivery are practical and documented. Access is materially narrower than the exact product page suggests because the provider limits availability by country and state, requires a physician requisition, requires adult eligibility, and requires supported internet-connected mobile access.

AgeRate publishes detailed collection, use, disclosure, access, security, research, and sample-transfer terms, including a no-sale statement and anonymization language for contracted laboratories. Privacy remains materially uncertain because storage may be indefinite, research and product-development uses are broad, deletion is qualified, and hosting geography is internally inconsistent.

AgeRate publishes an exact product route, a visible price, workflow pages, terms, privacy, refund, and shipping policies. Evaluation remains materially impaired by the exact-page content gap, absent named laboratory and assay details, absent report evidence, unresolved price and delivery conflicts, and incomplete membership terms.